Condition: Ovarian Cancer · Serous Ovarian Cancer · Sponsor: Sarah K. Lynam MD
To see how effective the study medicine combined with hormone therapy is when given to participants with recurrent low-grade serous ovarian cancer.
This description comes directly from the study's public registry record.
Sarah Lynam, MD · 1-800-641-2422 · Sarah.Lynam@UHhospitals.org
Nancy Fusco, RN · 216-844-3954 · nancy.fusco@UHhospitals.org
Always discuss trial participation with your own doctor first.
| University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05113368